Jerzy Krzysztof Wranicz
Overview
Explore the profile of Jerzy Krzysztof Wranicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wojtaszczyk A, Kaczmarek K, Urbanek I, Cygankiewicz I, Wranicz J
Kardiol Pol
. 2024 Feb;
82(4):434-437.
PMID: 38374781
No abstract available.
2.
Zatorska-Berner M, Berner R, Janicki M, Strzelecki A, Cygankiewicz I, Wranicz J, et al.
Kardiol Pol
. 2024 Jan;
82(3):318-320.
PMID: 38230470
No abstract available.
3.
Hindricks G, Theuns D, Bar-Lev D, Anguera I, Ayala Paredes F, Arnold M, et al.
Europace
. 2023 Apr;
25(5).
PMID: 37038759
Aims: To allow timely initiation of anticoagulation therapy for the prevention of stroke, the European guidelines on atrial fibrillation (AF) recommend remote monitoring (RM) of device-detected atrial high-rate episodes (AHREs)...
4.
Mrozowska D, Kaczmarek K, Dziuba M, Tylkowski M, Wranicz J
Pol Merkur Lekarski
. 2022 Oct;
50(299):282-286.
PMID: 36283009
Aim: The aim of the study was determination a value of seven electrocardiographic predictors of RV MI in prognosis of in-hospital complications in patients with inferior MI. Materials And Methods:...
5.
Kaczmarek K, Wojnicz R, Ptaszynski P, Wranicz J, Cygankiewicz I
Am J Case Rep
. 2022 Jul;
23:e935259.
PMID: 35905036
BACKGROUND Cardiac inflammatory pseudotumors are rarely observed. Their etiology might include immunologic abnormalities, fibrogenetic disorders, specific reactions to infections or abnormalities related to trauma, necrosis, or neoplasm. Life-threatening ventricular tachycardia...
6.
Wranicz J, Kalowski M, Bastian D, Jaswal A, Kolb C, Zitron E, et al.
Ann Noninvasive Electrocardiol
. 2022 Feb;
27(3):e12914.
PMID: 35170151
Background: The inSighT study was designed to determine the prevalence of ischemic changes as recorded by implantable cardioverter-defibrillator (ICD) ST deviations in intracardiac electrocardiograms (EGM) over the 24 h preceding...
7.
Drozdz J, Piotrowski G, Zielinska M, Wranicz J, Lubinski A, Krekora J, et al.
Kardiol Pol
. 2021 Jun;
79(5):572-574.
PMID: 34125933
No abstract available.
8.
Kaczmarek K, Cygankiewicz I, Streb W, Plaksej R, Jakubowski P, Kalarus Z, et al.
J Clin Med
. 2021 Mar;
10(4).
PMID: 33673147
We analyzed clinical experience with percutaneous closure of instances of left atrial appendage with thrombus (LAAT) irresponsive to antithrombotic therapy in patients treated in three high-volume cardiology centers. Clinical and...
9.
Abraham W, Lindenfeld J, Ponikowski P, Agostoni P, Butler J, Desai A, et al.
Eur Heart J
. 2020 Dec;
42(6):700-710.
PMID: 33351892
Aims: The EMPERIAL (Effect of EMPagliflozin on ExeRcise ability and HF symptoms In patients with chronic heArt faiLure) trials evaluated the effects of empagliflozin on exercise ability and patient-reported outcomes...
10.
Rozycka-Kosmalska M, Kosmalski M, Wranicz J
Pol Merkur Lekarski
. 2020 Jan;
47(282):207-211.
PMID: 31945020
Aim: The main aim of this study was to evaluate the effect of ABG to the risk of major cardiovascular events and the development of T2DM during one year follow-up...